ClinicalTrials.Veeva

Menu

Evaluation of Premixed Verses Powder/Liquid Bioceramic MTA in Indirect Pulp Capping.

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Indirect Pulp Capping

Treatments

Other: Premixed MTA
Other: Powder/liquid MTA

Study type

Interventional

Funder types

Other

Identifiers

NCT05597553
PM Mta verses P/L

Details and patient eligibility

About

Evaluate Clinical and Radiographic Evaluation of Premixed verses Powder / Liquid Bioceramic Mineral Trioxide Aggregate in Indirect Pulp Capping of Immature Permanent Mandibular Molars

Full description

Mineral trioxide aggregate (MTA) is a bioactive, biocompatible, antibacterial material with good stability, and excellent sealing ability that has been used as a dressing material in pulp capping procedures in permanent teeth.

Although it has good properties, MTA has many limitations, including long setting time, handling property and tooth discoloration making the use of this material challenging for many clinicians.

Researchers and manufacturers have made progress in overcoming these problems in recent years, new and improved products are becoming available such as the premixed bioceramic putty.

The premixed bioceramics putty are ready to use materials, fast setting, with superior handling properties and hydrophilic in nature that necessitate moisture from the adjacent tissues to set. They have advantage of insensitive to moisture and blood contamination with less technique sensitive. Upon setting, they become hard and expand slightly providing with superior long-term seal.

Premixed Bio-ceramics (BC) are highly alkaline materials (pH = 12.7), they release calcium and have antibacterial activity. Their biocompatibility is higher than that of MTA, this is attributed to the absence of heavy metals from the premixed BC components.

The premixed bio-ceramic putty (Well-Root™ PT) has been developed for the management of pulp capping procedures with the advantage of uniform homogenous consistency and lack of waste. It is radiopaque material based on a calcium aluminosilicate composition.

It has excellent biological & physical properties and does not shrink during setting. Well-Root™ PT does not create an inflammatory response and promotes mineralization.

Enrollment

24 estimated patients

Sex

All

Ages

6 to 8 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Medically fit and cooperative children.
  • Pediatric patients aged 6-8 years.
  • Deep caries with reversible pulpits in immature first permanent mandibular molars indicated for indirect pulp capping.
  • Absence of clinical signs and symptoms of pulpal exposure.
  • Absence of radiographic signs and symptoms of pulp degeneration.
  • Positive parental informed consent.

Exclusion criteria

  • Clinical symptoms of irreversible pulpitis requiring endodontic treatment.
  • Clinical symptoms of pulp exposure.
  • The presence of fistulas or swelling.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

24 participants in 2 patient groups

Premixed MTA
Experimental group
Description:
The premixed bioceramics putty are ready to use materials, fast setting, with superior handling properties and hydrophilic in nature that necessitate moisture from the adjacent tissues to set. They have advantage of insensitive to moisture and blood contamination with less technique sensitive.
Treatment:
Other: Premixed MTA
Other: Powder/liquid MTA
Powder/liquid MTA
Active Comparator group
Description:
Mineral trioxide aggregate (MTA) is a bioactive, biocompatible, antibacterial material with good stability, and excellent sealing ability that has been used as a dressing material in pulp capping procedures in permanent teeth, although it has good properties, it has many limitations, including long setting time, handling property and tooth discoloration making the use of this material challenging for many clinicians.
Treatment:
Other: Premixed MTA
Other: Powder/liquid MTA

Trial contacts and locations

0

Loading...

Central trial contact

Rania Nasr, Professor; Aisha MK Magdy, BDS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems